EFM
KYNB

E Fund Management’s Kyntra Bio KYNB Stock Holding History

E Fund Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-781
Closed -$53K – 303
2023
Q2 		$53K Buy
781
+223
+40% +$92.2K ﹤0.01% 309
2023
Q1 		$260K Buy
558
+14
+3% +$7.41K 0.02% 255
2022
Q4 		$218K Sell
544
-82
-13% -$31.4K 0.02% 288
2022
Q3 		$204K Sell
626
-72
-10% -$23.2K 0.02% 301
2022
Q2 		$184K Buy
698
+142
+26% +$36.3K 0.02% 306
2022
Q1 		$167K Buy
+556
New +$194K 0.01% 305
2021
Q4 		– Sell
-608
Closed -$155K – 305
2021
Q3 		$155K Buy
+608
New +$215K 0.01% 248

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

E Fund Management's KYNB Position: Q3 2023 in Review

E Fund Management sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 781 shares — an estimated $53K sold.

E Fund Management first reported a position in KYNB in Q3 2021 and held it in 7 quarters. The position peaked at $260K in Q1 2023. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • E Fund Management reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • E Fund Management sold 781 Kyntra Bio shares in Q3 2023, an estimated $53K.
  • E Fund Management first reported a position in Kyntra Bio in Q3 2021 and held it in 7 quarters.
  • E Fund Management's Kyntra Bio position peaked at $260K in Q1 2023.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on E Fund Management's 13F filing for Q3 2023, filed 13 Nov 2023.